NEOG Valuation

Neogen Corp

Add to Watchlist

Advanced Chart

5.740

+0.13(2.317%)1D

Overview
Forecast
Valuation
Earnings

NEOG Relative Valuation

NEOG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NEOG is overvalued; if below, it's undervalued.

Historical Valuation

Neogen Corp (NEOG) is now in the Fair zone, suggesting that its current forward PE ratio of 22.90 is considered Fairly compared with the five-year average of 42.67. The fair price of Neogen Corp (NEOG) is between 5.24 to 13.21 according to relative valuation methord.

Relative Value

Fair Zone

5.24-13.21

Current Price：5.74

Fair

22.90

Trailing

Forward

12.22

EV/EBITDA

Neogen Corp. (NEOG) has a current EV/EBITDA of 12.22. The 5-year average EV/EBITDA is 22.53. The thresholds are as follows: Strongly Undervalued below 0.24, Undervalued between 0.24 and 11.39, Fairly Valued between 33.68 and 11.39, Overvalued between 33.68 and 44.82, and Strongly Overvalued above 44.82. The current Forward EV/EBITDA of 12.22 falls within the Historic Trend Line -Fairly Valued range.

-154.27

EV/EBIT

Neogen Corp. (NEOG) has a current EV/EBIT of -154.27. The 5-year average EV/EBIT is 81.33. The thresholds are as follows: Strongly Undervalued below -147.94, Undervalued between -147.94 and -33.31, Fairly Valued between 195.96 and -33.31, Overvalued between 195.96 and 310.60, and Strongly Overvalued above 310.60. The current Forward EV/EBIT of -154.27 falls within the Strongly Undervalued range.

1.48

Neogen Corp. (NEOG) has a current PS of 1.48. The 5-year average PS is 5.06. The thresholds are as follows: Strongly Undervalued below -0.19, Undervalued between -0.19 and 2.43, Fairly Valued between 7.69 and 2.43, Overvalued between 7.69 and 10.31, and Strongly Overvalued above 10.31. The current Forward PS of 1.48 falls within the Undervalued range.

8.58

P/OCF

Neogen Corp. (NEOG) has a current P/OCF of 8.58. The 5-year average P/OCF is 16.16. The thresholds are as follows: Strongly Undervalued below -55.10, Undervalued between -55.10 and -19.47, Fairly Valued between 51.79 and -19.47, Overvalued between 51.79 and 87.42, and Strongly Overvalued above 87.42. The current Forward P/OCF of 8.58 falls within the Historic Trend Line -Fairly Valued range.

7.77

P/FCF

Neogen Corp. (NEOG) has a current P/FCF of 7.77. The 5-year average P/FCF is 35.60. The thresholds are as follows: Strongly Undervalued below -198.69, Undervalued between -198.69 and -81.54, Fairly Valued between 152.75 and -81.54, Overvalued between 152.75 and 269.90, and Strongly Overvalued above 269.90. The current Forward P/FCF of 7.77 falls within the Historic Trend Line -Fairly Valued range.

Neogen Corp (NEOG) has a current Price-to-Book (P/B) ratio of 0.59. Compared to its 3-year average P/B ratio of 1.08 , the current P/B ratio is approximately -45.53% higher. Relative to its 5-year average P/B ratio of 2.58, the current P/B ratio is about -77.24% higher. Neogen Corp (NEOG) has a Forward Free Cash Flow (FCF) yield of approximately -3.80%. Compared to its 3-year average FCF yield of -1.92%, the current FCF yield is approximately 98.18% lower. Relative to its 5-year average FCF yield of -0.52% , the current FCF yield is about 628.06% lower.

0.59

P/B

Median3y

1.08

Median5y

2.58

-3.80

FCF Yield

Median3y

-1.92

Median5y

-0.52

Competitors Valuation Multiple

The average P/S ratio for NEOG's competitors is 0.00, providing a benchmark for relative valuation. Neogen Corp Corp (NEOG) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -4.79%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

BioLife Solutions Inc

Pulse Biosciences Inc

Loss

1.18B

KMTS.O

Kestra Medical Technologies Ltd

Establishment Labs Holdings Inc

SS Innovations International Inc

Loss

128.00%

1.19B

Performance Decomposition

Market capitalization of NEOG decreased by 65.85% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.29 to -271.53.

The secondary factor is the Revenue Growth, contributed -4.79%to the performance.

Overall, the performance of NEOG in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-4.79%

236.79M → 225.46M

Revenue Growth

11757.21%

-2.29 → -271.53

Margin Expansion

-11818.27%

0.01 → -1.14

P/E Change

-65.85%